Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that is often increased
in malignancies such as non–small cell lung cancer, metastatic colorectal cancer, head and …

Conventional chemotherapy is associated with poor outcomes in metastatic renal cell
carcinoma (RCC). Advances in the understanding of tumor molecular biology and the …

目的观察唑来膦酸联合厄罗替尼治疗晚期非小细胞肺癌(NSCLC) 骨转移的疗效及安全性,
并进行相关文献复习. 方法将60 例NSCLC 晚期骨转移患者随机分为两组, 唑来膦酸组30 例 …

Of the common cancers, pancreatic ductal adenocarcinoma is one of the most lethal. The
cancer's aggressive biology, leading to rapid dissemination, combined with a lack of clearly …

背景与目的厄洛替尼在NSCLC 患者中已有广泛应用, 并能使部分NSCLC 患者明显获益.
本研究探讨厄洛替尼单药一线或二, 三线治疗晚期非小细胞肺癌的临床疗效及毒副反应 …

Colorectal cancer (CRC) is the most commonly diagnosed fatal cancer in both women and
men worldwide. CRC ranked second in mortality and third in incidence in 2020. It is difficult …

Erlotinib (Tarceva™) is an epidermal growth factor receptor (EGFR) inhibitor, a member of a
new group of molecular targeted drugs that combine high efficacy against tumours with less …

Purpose: Rash is the most common side effect of epidermal growth factor receptor (EGFR)
inhibitors and negatively impacts quality of life. This single-institution study sought to explore …

Compounds 1 (N 1-(3-ethynylphenyl)-6-methyl-N 5-(3-(6-(methylamino) pyrimidin-4-yl)
pyridin-2-yl) isoquinoline-1, 5-diamine) and 2 (N-(3-ethynylphenyl)-6, 7-bis (2 …

胰腺癌预后不良, 死亡率高居消化道癌症第5 位. 现代医学对胰腺癌的病因尚未完全清楚,
但随着肿瘤发生, 发展分子机制的逐步了解, 癌细胞与正常细胞的区别将会更加明确 …